Literature DB >> 4598612

Bactericidal activity and pharmacology of cefazolin.

M G Bergeron, J L Brusch, M Barza, L Weinstein.   

Abstract

The in vitro bactericidal activity of cefazolin was found to be similar to that of cephaloridine and cephalothin but slightly greater than that of cephalexin against a majority of 233 strains of gram-positive and gram-negative organisms. Cefazolin, however, was two- to eightfold more active than the other two drugs against Escherichia coli and klebsiella. The mean peak concentrations in the serum in 10 normal subjects 1 h after intramuscular injections of 1,000, 500, and 250 mg of cefazolin were 38.8, 18.6, and 12.2 mug/ml, respectively. The antibiotic could still be detected at 8 h. Peak values for a given dose of cephaloridine were comparable. However, blood levels of cefazolin were regularly higher than those of cephaloridine over the first 8 h. The mean half-life of cefazolin in the serum was 2 h, whereas that of cephaloridine was 1.4 h. The degree of serum protein-binding was strikingly higher for cefazolin (81%) than for cephaloridine (24%), suggesting that the antibacterial activity of the former in serum might be less than that of cephaloridine after equal doses. This proved to be the case when the bacterial activity of blood drawn 1, 4, and 8 h after injection of the two drugs was examined.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4598612      PMCID: PMC444566          DOI: 10.1128/AAC.4.4.396

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity.

Authors:  M Nishida; T Matsubara; T Murakawa; Y Mine; Y Yokota
Journal:  J Antibiot (Tokyo)       Date:  1970-03       Impact factor: 2.649

2.  In vitro assessment of tobramycin, a new aminoglycoside with anti-Pseudomonas activity.

Authors:  A Molavi; M Barza; W Cole; H Berman; L Weinstein
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

3.  Clinical studies of cefazolin in the surgical field.

Authors:  K Shibata; M Fujii
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

4.  In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative.

Authors:  M Nishida; T Matsubara; T Murakawa; Y Mine; Y Yokota; S Kuwahara; S Goto
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

5.  Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.

Authors:  M Nishida; T Matsubara; T Murakawa; Y Mine; Y Yokota; S Goto; S Kuwahara
Journal:  J Antibiot (Tokyo)       Date:  1970-04       Impact factor: 2.649

6.  Absorption, tissue concentration, and organ distribution of cefazolin.

Authors:  S Ishiyama; I Nakayama; H Iwamoto; S Iwai; M Okui
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

7.  In vitro activity of cephalosporin antibiotics against Gram-positive bacteria.

Authors:  F H Kayser
Journal:  Postgrad Med J       Date:  1971-02       Impact factor: 2.401

8.  Therapeutic implications of serum protein binding of the new semisynthetic penicillins.

Authors:  C M Kunin
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

9.  Cefazolin, a new semisynthetic cephalosporin antibiotic. I. Synthesis and chemical properties of cefazolin.

Authors:  K Kariyone; H Harada; M Kurita; T Takano
Journal:  J Antibiot (Tokyo)       Date:  1970-03       Impact factor: 2.649

10.  Cefazolin, a new semisynthetic cephalosporin antibiotic. VI. Excretion and metabolism of cefazolin- 14 C in rats after intramuscular administration.

Authors:  J Kozatani; M Okui; T Matsubara; M Nishida
Journal:  J Antibiot (Tokyo)       Date:  1972-02       Impact factor: 2.649

View more
  26 in total

1.  Quantitative assessment of bactericidal activities of beta-lactam antibiotics by agar plate method.

Authors:  G Masuda; S Tomioka
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

2.  Effects of renal failure and dialysis on cefazolin pharmacokinetics.

Authors:  T Madhavan; K Yaremchuk; N Levin; E Fisher; F Cox; K Burch; E Haas; D Pohlod; E L Quinn
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

3.  Penetration of cefazolin into pleural fluid.

Authors:  D R Cole; J Pung
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

4.  Cefuroxime: human pharmacokinetics..

Authors:  R D Foord
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

5.  Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.

Authors:  E C Ernst; S Berger; M Barza; N V Jacobus; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

6.  Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study.

Authors:  M Schäfer-Korting; H C Korting; F Amann; R Peuser; A Lukacs
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

7.  [Letter: On P. Naumann's article; On the current status of standardization of resistance determination in Germany].

Authors: 
Journal:  Infection       Date:  1974       Impact factor: 3.553

8.  In vitro studies with cefazolin.

Authors:  M Motley; S Shadomy
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

9.  Activity of four cephalosporin antibiotics in vitro against bovine udder pathogens and pathogenic bacteria isolated from newborn calves.

Authors:  G Ziv
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

10.  [An investigation into the influence of human serum on the in-vitro activity of various cephalosporins (author's transl)].

Authors:  R Ratschow; J R Krone
Journal:  Infection       Date:  1977       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.